class action lawsuit semaglutide A class-action has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Ozempic makers face proposed class

Meng, J

In terms of immune modulation, GLP-1RAs demonstrate a bidirectional mechanism: they can enhance anti-tumor immune responses while modulating systemic inflammatory processes

Meet Eddie Hughes, FNP-BC With over 15 years of healthcare experience spanning emergency medicine, neurosurgery, hospital medicine, and regenerative medicine, Eddie Hughes brings a depth of clinical knowledge that most weight loss providers simply dont have

Unlike some other vitamins, cobalamin is not synthesized in the body

Novo Nordisk is currently running two large Phase 3 trials to investigate the effect of GLP-1 drugs on Alzheimer's disease, based on early data suggesting reduced neuroinflammation, improved cognition and function, and enhanced memory, as well as trials in which GLP-1 drugs appeared to substantially reduce dementia rates in diabetes patients